We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+2.66%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$905M
AUM Growth
-$258M
Cap. Flow
-$235M
Cap. Flow %
-25.96%
Top 10 Hldgs %
40.21%
Holding
233
New
72
Increased
5
Reduced
36
Closed
79

Top Buys

Rank Stock Value
1
KROS icon
Keros Therapeutics
KROS
+$23.4M
2
TIGO icon
Millicom
TIGO
+$7.17M
3
SIMO icon
Silicon Motion
SIMO
+$5.32M
4
ANEB
Anebulo Pharmaceuticals
ANEB
+$4.16M
5
CHARU
Charlton Aria Acquisition Corp Units
CHARU
+$3.66M

Top Sells

Rank Stock Value
1
JXN icon
Jackson Financial
JXN
+$37.5M
2
JOYY
JOYY Inc
JOYY
+$37.2M
3
ANAB icon
AnaptysBio
ANAB
+$23.1M
4
IBIT icon
iShares Bitcoin Trust
IBIT
+$15.7M
5
TSEM icon
Tower Semiconductor
TSEM
+$13.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.6%
2 Consumer Discretionary 16.13%
3 Financials 11.79%
4 Communication Services 11.74%
5 Technology 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLYVK icon
1
Liberty Live Group Series C
LLYVK
$9.11B
$43.3M 4.78%
636,123
– –
ATMU icon
2
Atmus Filtration Technologies
ATMU
$4.37B
$43.1M 4.76%
1,099,631
-82,295
-7% -$3.34M
TEVA icon
3
Teva Pharmaceuticals
TEVA
$35.9B
$42.6M 4.71%
1,932,427
-214,714
-10% -$3.91M
ENVA icon
4
Enova International
ENVA
$5.91B
$39.8M 4.4%
415,160
-41,425
-9% -$3.95M
LBRDK icon
5
Liberty Broadband Class C
LBRDK
$4.15B
$37.9M 4.19%
506,776
-24,778
-5% -$2.07M
LAUR icon
6
Laureate Education
LAUR
$5.18B
$35.3M 3.9%
1,930,871
-70,484
-4% -$1.24M
AER icon
7
AerCap
AER
$23.9B
$32.6M 3.61%
340,904
-37,878
-10% -$3.63M
MBC icon
8
MasterBrand
MBC
$1.09B
$31.7M 3.5%
2,169,520
-147,323
-6% -$2.51M
MREO
9
Mereo BioPharma
MREO
$45.9M
$30.2M 3.34%
8,636,485
-93,235
-1% -$366K
TSEM icon
10
Tower Semiconductor
TSEM
$26.4B
$27.4M 3.02%
531,305
-281,738
-35% -$13.2M
WS icon
11
Worthington Steel
WS
$1.8B
$26.9M 2.97%
844,144
-146,625
-15% -$5.72M
SSNC icon
12
SS&C Technologies
SSNC
$17.8B
$26.7M 2.95%
352,849
-39,206
-10% -$2.93M
IJR icon
13
iShares Core S&P Small-Cap ETF
IJR
$109B
$25.7M 2.84%
223,300
– –
BRSL
14
Brightstar Lottery PLC
BRSL
$1.91B
$24.6M 2.72%
1,395,724
-133,197
-9% -$2.62M
BLCO icon
15
Bausch + Lomb
BLCO
$5.77B
$19.1M 2.11%
1,059,133
-92,159
-8% -$1.8M
AUR icon
16
Aurora
AUR
$11.7B
$17.7M 1.96%
2,815,036
– –
VAL icon
17
Valaris
VAL
$5.51B
$16.7M 1.85%
377,909
-41,990
-10% -$2.02M
CENTA icon
18
Central Garden & Pet Co Class A
CENTA
$2.41B
$16.3M 1.8%
493,056
– –
SGI
19
Somnigroup International
SGI
$15.1B
$16.3M 1.8%
286,891
-31,877
-10% -$1.7M
UBS icon
20
UBS Group
UBS
$170B
$16M 1.77%
527,637
-131,909
-20% -$4.18M
LNTH icon
21
Lantheus
LNTH
$6.82B
$15.7M 1.73%
175,236
-19,471
-10% -$1.9M
PTGX icon
22
Protagonist Therapeutics
PTGX
$8.75B
$15.3M 1.69%
395,383
-43,931
-10% -$1.92M
RIO icon
23
Rio Tinto
RIO
$148B
$14.7M 1.62%
249,490
– –
PPLI
24
People Inc
PPLI
$3.1B
$14.6M 1.61%
412,806
– –
KROS icon
25
Keros Therapeutics
KROS
$199M
$11.7M 1.29%
736,385
+449,390
+157% +$23.4M
1
2 3 4 5

Similar funds

GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Mangrove Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Mangrove Partners held 233 positions worth $905M, down 22% from $1.16B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Mangrove Partners withdrew a net $235M in Q4 2024, closing 79 positions and reducing 36 holdings. Its most notable exit was Jackson Financial, an estimated $37.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Mangrove Partners opened a new position in Millicom worth $6.84M.

  • Mangrove Partners's largest Q4 2024 buy was Millicom: 273,463 shares worth $6.84M.
  • Mangrove Partners added most to Keros Therapeutics in Q4 2024, an estimated $23.4M increase.
  • Mangrove Partners's biggest Q4 2024 reduction was Tower Semiconductor, cutting an estimated $13.2M.
  • Mangrove Partners fully exited Jackson Financial in Q4 2024, selling an estimated $37.5M.
  • Mangrove Partners's ten largest holdings make up 40% of its $905M portfolio in Q4 2024.
  • Mangrove Partners opened 72 new positions and closed 79 in Q4 2024.
  • Mangrove Partners's portfolio value fell 22% quarter-over-quarter to $905M.

Based on Mangrove Partners's 13F filing for Q4 2024, filed 14 Feb 2025.